Volume 24, Issue 4 pp. 533-541
ORIGINAL ARTICLE

Musculoskeletal sarcoidosis: A single center experience over 15 years

Sanjeev Patil

Sanjeev Patil

Rheumatology, The University of Vermont Medical Center, Burlington, VT, USA

Search for more papers by this author
Carolyn A. Hilliard

Carolyn A. Hilliard

Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Search for more papers by this author
Masumi Arakane

Masumi Arakane

Northern Colorado Hospitalists, Fort Collins, CO, USA

Search for more papers by this author
Sreedevi Koppisetti Jenigiri

Sreedevi Koppisetti Jenigiri

Division of Nephrology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Search for more papers by this author
Elizabeth H. Field

Elizabeth H. Field

Division of Immunology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Search for more papers by this author
Namrata Singh

Corresponding Author

Namrata Singh

Division of Rheumatology, Department of Internal Medicine, University of Washington, Seattle, WA, USA

Correspondence

Namrata Singh, Division of Rheumatology, Department of Internal Medicine, University of Washington, Seattle, WA 98195, USA.

Email: [email protected]

Search for more papers by this author
First published: 09 February 2021
Citations: 4

Abstract

Background

Musculoskeletal (MSK) sarcoidosis presents with a variety of clinical phenotypes. Four subtypes of MSK sarcoidosis have been identified to date: Lofgren syndrome, chronic sarcoid arthritis, osseous sarcoidosis, sarcoid myopathy. Each subtype has been reported with varying incidence mainly due to lack of universal classification criteria.

Methods

We performed a retrospective chart review of patients with MSK sarcoidosis at a single academic center between January 2000 and December 2014. Descriptive statistics were used to describe the proportion of patients with sarcoidosis who had the 4 MSK syndromes of interest, demographic characteristics and therapeutic agents used.

Results

A cohort of 58 patients with MSK manifestations were identified among 1016 patients with sarcoidosis. Frequency of subtypes include: Lofgren syndrome 46.6%, osseous sarcoidosis 25.9%, chronic sarcoid arthritis 24.1% and sarcoid myopathy 6.9%. The cohort was predominantly female (43/58 patients, 74%) and Caucasian (48/58 patients, 82.8%). Mean age was 47.2 years. One patient had overlap of osseous sarcoidosis and chronic sarcoid arthritis, another patient initially had Lofgren syndrome and later developed chronic sarcoid arthritis. Sarcoid myopathy patients presented with myalgia more often than muscle weakness.

Conclusion

We identified a large cohort of MSK sarcoidosis and determined the prevalence of all 4 subtypes. In patients who do develop MSK manifestations of sarcoidosis, they are commonly a part of the initial presentation of sarcoidosis. There is an unmet need to establish standardized classification criteria for the 4 MSK sarcoidosis syndromes.

CONFLICT OF INTEREST

Dr Singh is funded by the Rheumatology Research Foundation. Other authors have no conflicts of interest to disclose.

DATA AVAILABILITY STATEMENT

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.